Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials

By afschroeder • October 23, 2025

Gresham G, Henry NL, Bandos H, Calsavara VF, Cecchini RS, Diniz MA, Hays RD, Luu M, Kim S, Rogatko A, Yothers G, Ganz PA, Tighiouart M. Analyses of adverse events and patient-reported outcomes with the toxicity index in cancer clinical trials. Cancer. 2025 Oct 15;131 Suppl 2:e70086. doi: 10.1002/cncr.70086. PMID: 41123586.

Tags: biostatistics, cancer clinical trials, Cedars Sinai DoM, General Internal Medicine, Hematology/Oncology, patient‐reported outcomes, Publications, toxicity, toxicity index, Treatment tolerability

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

Discontinuation of statins by patient and physician sex: An observational study

Watanabe A, Miyamoto Y, Ueyama HA, Gotanda H, Slipczuk L, Inoue K, Secemsky E, Laham R, Bhatt DL, Tsugawa Y, Kuno T. Discontinuation of statins[...]

Cohort Study of Initial Diuretic Dosing and Outcomes Among Patients Hospitalized for Congestive Heart Failure: Insights From the Cardiovascular Quality Improvement and Care Innovation Consortium

Qadri N, Kwok E, Stanberry L, Thomas C, Irausquin SJ, Gupta D, Ebinger JE, Gluckman TJ, Mutharasan RK, Goyal A, Brownell NK, Scirica BM, Ho[...]